News | December 01, 2025
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
_256_384.jpg)
The transaction is expected to be completed within one month from the signing of the definitive agreements.
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Subscribe To Our Newsletter & Stay Updated
